Smart Syringe Market, by Product Type (Auto-disable Syringes, Active Safety Syringes, and Passive Safety Syringes), by Application (Vaccination, Drug Delivery, and Blood Specimen Collection), by End User (Hospitals & Clinics, Diagnostic Laboratories, and Homecare Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023

Code : CMI4394

Pages :210

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Global Smart Syringe Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global smart syringe market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. The global smart syringe market is expected to witness significant growth in the coming years, owing to increasing investment and funding to support COVID-19 vaccination in the North America region. For instance, in June 2021, the World Bank, an international financial institution, approved a US$100 million grant from the International Development Association (IDA), a development finance institution and a US$15 million grant from the Global Financing Facility (GFF), an investing firm, in support of Mozambique’s efforts to expand its current COVID-19 vaccination campaign. The funds were used to manage and distribute COVID-19 vaccines, strengthen the preparedness and capacity of national health systems, and ensure the continuity of essential health services, especially for women, children, and adolescents.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa